Cenestin Settlement: Barr Boosts Branded Business With Five Wyeth Products
Executive Summary
Barr will add an oral contraceptive in development at Wyeth as part of an acquisition deal that settles Cenestin antitrust litigation
You may also be interested in...
Market Share Movement Contracts Remain Of Interest To Prosecutor
Market share movement contracts are potentially troubling if the end result is that patients are taken off therapy altogether, Philadelphia Associate U.S. Attorney James Sheehan suggested during the National Community Pharmacists Association legislative conference May 20 in Washington, D.C
Market Share Movement Contracts Remain Of Interest To Prosecutor
Market share movement contracts are potentially troubling if the end result is that patients are taken off therapy altogether, Philadelphia Associate U.S. Attorney James Sheehan suggested during the National Community Pharmacists Association legislative conference May 20 in Washington, D.C
Wyeth Cost-Cutting Will Spare Effexor, Manufacturing Investments
Wyeth will invest $60 mil. in Effexor manufacturing capacity expansion in 2003, CFO Kenneth Martin told the Credit Suisse First Boston investor conference Nov. 14 in Phoenix